Sorrento Therapeutics News

Sorrento Therapeutics | 8-K: Current report

Nov 7, 2023 16:34 ET

Sorrento Therapeutics | 8-K: Current report

Nov 3, 2023 17:31 ET

Sorrento Therapeutics | 8-K: Current report

Oct 27, 2023 16:15 ET

Sorrento Therapeutics | 8-K: Current report

Oct 5, 2023 17:26 ET

Sorrento Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sorrento Therapeutics, Inc.(2.6%)

Oct 5, 2023 17:22 ET

Sorrento Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Sorrento Therapeutics, Inc.

Oct 5, 2023 17:16 ET

Sorrento Therapeutics | 8-K: Current report

Sep 26, 2023 16:54 ET

Sorrento Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sorrento Therapeutics, Inc.(1.3%)

Sep 26, 2023 16:49 ET

Sorrento Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Sorrento Therapeutics, Inc.

Sep 25, 2023 16:27 ET

Sorrento Therapeutics | 8-K: Current report

Sep 12, 2023 21:51 ET

Sorrento Therapeutics | 8-K: Current report

Aug 28, 2023 17:25 ET

Sorrento Therapeutics | 8-K: Current report

Aug 21, 2023 11:20 ET

Sorrento Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sorrento Therapeutics, Inc.(43.3%)

Aug 14, 2023 20:59 ET

Sorrento Therapeutics | 10-Q: Q2 2023 Earnings Report

Aug 11, 2023 20:00 ET

Sorrento Therapeutics | 8-K: Current report

Aug 10, 2023 16:14 ET

Sorrento Therapeutics | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Aug 7, 2023 16:15 ET

Sorrento Therapeutics | 8-K: Current report

Aug 1, 2023 06:01 ET

Sorrento Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Jul 18, 2023 17:23 ET

Sorrento Therapeutics | 8-K: Current report

Jul 13, 2023 06:26 ET

Sorrento Therapeutics | 8-K: Current report

Jul 7, 2023 21:49 ET